Q2 2026 13F · SEC CIK 1802451

HighMark Wealth Management LLC

Wealth managerFiled 2026-08-12 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value: $298.5M
Reported positions: 561
Top holdings a year, 3 yrs: +22.6%
Assets under management: $611.7M

HighMark Wealth Management LLC is a wealth manager that reported 561 positions worth $298.5M in its Q2 2026 13F, filed 2026-08-12. Its largest holdings were Ishares Core S&p 500 ETF (IVV, 27.6%), Fidelity Msci Health Care Index ETF (FHLC, 6.6%), Axogen Inc (AXGN, 5.3%). A portfolio copying its top holdings returned 22.6% a year over the last 3 years, against 20.4% for the S&P 500.

HighMark Wealth Management LLC holdings largest 50 of 561 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

HighMark Wealth Management LLC 13F holdings
Stock	% of 13F value	Q1 2026	Shares	Share change	Reported value
IVVIshares Core S&p 500 ETF	27.6%	31.0%	109,892	-6.0%	$82.3M
FHLCFidelity Msci Health Care Index ETF	6.6%	—	254,403	—	$19.7M
AXGNAxogen Inc	5.3%	4.7%	341,390	-1.0%	$15.8M
IWMIshares	5.1%	5.5%	51,019	-6.6%	$15.3M
EFVIshares Tr	5.1%	6.7%	199,183	-9.6%	$15.2M
IJRIshares Core S&p Small Cap ETF	4.5%	4.6%	89,888	-0.9%	$13.3M
VOOVanguard S&p 500 ETF	3.6%	4.0%	15,529	-5.9%	$10.7M
NEONeogenomics Inc	3.0%	1.8%	612,534	+5.6%	$8.9M
IUSVIshares Tr	2.8%	3.3%	75,506	-6.2%	$8.3M
SIBNSI-BONE Inc	2.3%	0.8%	425,049	+165.9%	$6.9M
DWASInvesco Exch Traded Fd Tr II	2.0%	1.9%	46,538	-0.7%	$5.9M
WFCWells Fargo Co New	1.9%	2.2%	68,644	+0.1%	$5.7M
IJHIshares Tr	1.6%	1.7%	62,399	+2.8%	$4.8M
APGEApogee Therapeutics Inc	1.4%	—	32,266	—	$4.3M
TWSTTwist Bioscience Corp	1.3%	0.8%	39,030	-0.7%	$4.0M
DUOTDuos Technologies Group Inc	1.2%	—	289,884	—	$3.5M
TLTIshares 20 Year Treasury Bond ETF	1.0%	1.3%	36,113	+1.0%	$3.1M
MASS908 Devices Inc	1.0%	0.8%	339,783	+6.4%	$3.0M
ANABAnaptysbio Inc	0.9%	2.1%	39,716	-57.8%	$2.7M
NPCENeuropace Inc	0.9%	0.3%	163,000	+158.7%	$2.6M
NVDANvidia Corporation Com	0.8%	0.9%	11,844	-7.3%	$2.4M
ATRCAtriCure, Inc.	0.8%	1.0%	83,720	+0.0%	$2.3M
AAPLApple Inc	0.7%	0.8%	7,608	-3.0%	$2.2M
EWTXEdgewise Therapeutics Inc	0.7%	0.7%	53,179	+0.0%	$2.2M
LLYLilly Eli & Co	0.7%	0.6%	1,734	+0.3%	$2.1M
TRVTravelers Companies Inc	0.6%	0.7%	5,606	+0.6%	$1.9M
MSFTMicrosoft Corp	0.6%	0.7%	4,684	+4.0%	$1.7M
HCATHealth Catalyst Inc	0.6%	0.5%	871,082	-3.5%	$1.7M
MMM3m Co Com	0.5%	0.6%	9,733	-0.3%	$1.6M
IJJiShares S&P Midcap 400 Value	0.5%	0.5%	9,998	+7.8%	$1.5M
CRNXCrinetics Pharmaceuticals in	0.5%	0.3%	38,595	+88.3%	$1.4M
IWNIshares Russell 2000 Value ETF	0.5%	0.5%	6,475	+7.6%	$1.4M
XENEXenon Pharmaceuticals Inc	0.5%	0.5%	23,000	+0.0%	$1.4M
IVEIshares S&p 500 Value ETF	0.4%	0.5%	5,909	+2.9%	$1.3M
TSLATesla Inc Com	0.4%	0.4%	2,834	+0.0%	$1.2M
XELXcel Energy Inc	0.4%	0.4%	13,138	+0.5%	$1.1M
LQDIshares Tr	0.3%	0.4%	9,335	+3.7%	$1.0M
USBUS Bancorp Del	0.3%	0.4%	16,643	-1.9%	$1.0M
VTIVanguard Index Fds	0.3%	0.3%	2,482	+0.3%	$919K
AGGIshares Tr	0.3%	0.4%	9,230	+2.0%	$914K
HSBCHsbc Hldgs PLC	0.3%	0.3%	9,008	+0.0%	$857K
SPYSpdr S&p 500 ETF Tr	0.3%	0.3%	1,081	-3.7%	$807K
GOOGLAlphabet Inc	0.3%	0.2%	2,193	+8.2%	$784K
PGProcter & Gamble Co Com	0.3%	0.3%	5,210	+1.4%	$764K
AMZNAmazon Com Inc Com	0.2%	0.2%	2,983	+5.2%	$711K
SPEMState Street Spdr Portfolio Emerging Mar	0.2%	0.3%	13,425	-10.5%	$695K
AUPHAurinia Pharmaceuticals Inc	0.2%	—	35,196	—	$597K
ECLEcolab Inc	0.2%	0.2%	2,101	+0.3%	$585K
MOAltria Group Inc	0.2%	—	7,889	—	$568K
JTEKJ P Morgan Exchange Traded F	0.2%	—	5,085	—	$567K

What HighMark Wealth Management LLC bought and sold in Q2 2026, against Q1 2026.

New positions

Q1 2026's filing was too long to tell new positions apart.

Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.

How the holdings did against the S&P 500.

1 year: +34.9% /yr; S&P 500 +20.1%
3 years: +22.6% /yr; S&P 500 +20.4%
5 years: +11.8% /yr; S&P 500 +11.6%

A portfolio of the filer's 20 largest 13F positions, weighted by value and rebuilt each quarter on the day the filing became public. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter	13F value	Positions
Q2 2026	$298.5M	561
Q1 2026	$245.6M	554
Q4 2025	$245.4M	587
Q3 2025	$227.1M	607
Q2 2025	$204.5M	616
Q1 2025	$169.3M	574
Q4 2024	$173.9M	575
Q3 2024	$182.7M	596
Q2 2024	$166.2M	586
Q1 2024	$161.5M	567
Q4 2023	$135.7M	575
Q3 2023	$120.6M	566

Questions about HighMark Wealth Management LLC's portfolio

What stocks does HighMark Wealth Management LLC own?

HighMark Wealth Management LLC's latest 13F, for Q2 2026 and filed Aug 12, 2026, lists 561 positions worth $298.5M. The largest are Ishares Core S&p 500 ETF (IVV) at 27.6%, Fidelity Msci Health Care Index ETF (FHLC) at 6.6%, Axogen Inc (AXGN) at 5.3%, Ishares (IWM) at 5.1% and Ishares Tr (EFV) at 5.1%.

What did HighMark Wealth Management LLC buy last quarter?

In Q2 2026, HighMark Wealth Management LLC added SI-BONE Inc (SIBN) (+165.9% shares), Neuropace Inc (NPCE) (+158.7% shares) and Crinetics Pharmaceuticals in (CRNX) (+88.3% shares), compared with its Q1 2026 filing.

What did HighMark Wealth Management LLC sell last quarter?

In Q2 2026, HighMark Wealth Management LLC cut from its top 50 Centessa Pharmaceuticals PLC (CNTA), cut from its top 50 Piper Sandler Companies (PIPR), cut from its top 50 Organogenesis Hldgs Inc (ORGO), cut from its top 50 Tandem Diabetes Care Inc (TNDM), cut from its top 50 Alphatec Hldgs Inc (ATEC), Anaptysbio Inc (ANAB) (-57.8% shares), State Street Spdr Portfolio Emerging Mar (SPEM) (-10.5% shares) and Ishares Tr (EFV) (-9.6% shares), compared with its Q1 2026 filing.

How has HighMark Wealth Management LLC's portfolio performed?

A portfolio copying HighMark Wealth Management LLC's 20 largest 13F holdings each quarter, from the day each filing was public, returned +22.6% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +34.9% against +20.1%. Over 5 years: +11.8% a year against +11.6%.

When is HighMark Wealth Management LLC's next 13F filing due?

13F filings are due 45 days after each quarter ends. HighMark Wealth Management LLC's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.

How much money does HighMark Wealth Management LLC manage?

HighMark Wealth Management LLC reported $611.7M of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $298.5M.